Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02036710 · ClinicalTrials.gov registry record
Location of GLP-1 Release
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 12
- Enrollment target
NCT02036710 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 12 participants.
The verdict
NCT02036710 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
Background: Physicians do not have a unified, scientifically tested theory of causation for obesity and its comorbidities, nor do they have explanations for the mechanics of the metabolic/bariatric surgery procedures. Integral to proffered hypotheses are the actions of the hormones glucagon-like peptide (GLP-1), peptide YY (PYY), and leptin. Study objective: To obtain blood levels of GLP-1, PYY, and leptin after stimulation of the terminal ileum and cecum by a static infusion of a food hydrolysate in morbidly obese patients undergoing a duodenal switch procedure. Methods: Plasma levels of GLP-1, PYY, and leptin were obtained at 0, 30, 60, 90, and 120 minutes after instillation of 240 ml of a food hydrolysate into the ileum or cecum.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2011-11 |
| Est. Completion | 2013-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02036710
The ClinicalTrials.gov registry entry for NCT02036710 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02036710 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02036710 about?
NCT02036710 is a clinical study titled "Location of GLP-1 Release". Background: Physicians do not have a unified, scientifically tested theory of causation for obesity and its comorbidities, nor do they have explanations for the mechanics of the metabolic/bariatric surgery procedures. Integral to proffered hypotheses are the actions of the hormones glucagon-like pep...
What is the current status of trial NCT02036710?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2011-11. Estimated completion is 2013-10.
Who is sponsoring clinical trial NCT02036710?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.